openPR Logo
Press release

Malignant Mesothelioma Market to Pegged to be Valued at US$ 600 Mn by 2025

Malignant Mesothelioma Market to Pegged to be Valued at US$ 600 Mn

In 2017, the global malignant mesothelioma market is expected to reach a value of US$ 338 Mn. The report observes that increasing use of asbestos for commercial purposes is fuelling the incidence of malignant mesothelioma among people. By the end of 2025, the global market for malignant mesothelioma is anticipated to have soared at 7.5% CAGR, reaching an estimated US$ 604 Mn in value.

In developed countries, discretionary research funding for cancer is on a rise. Increased investments towards development of better treatment against malignant mesothelioma is observed globally. Persistence Market Research’s new report on global market for malignant mesothelioma predicts that governments will increase their focus towards creating awareness about mesothelioma in the future. The global malignant mesothelioma market is expected to incur favorable boost from increased healthcare spending witnessed in multiple parts of the world, coupled with availability of better treatment prognosis for mesothelioma.

Browse Report Overview @ https://www.persistencemarketresearch.com/market-research/malignant-mesothelioma-market.asp

In addition to this, malignant mesothelioma is gaining incidence among men. Exposure to asbestos is likely to remain concentrated to male demographics of the world. Increased exposure to such toxic elements is aggravating the incidence of mesothelioma in men. Key players in the global malignant mesothelioma market are also collaborating with leading research organizations to develop combination drugs on mesothelioma, the approval of which is drawing highest regard of authorities such as the FDA.

The report has profiled leading players in the global malignant mesothelioma market, and they include Sanofi, Eli Lilly and Company, Teva Pharmaceuticals, Boehringer Ingelheim GmbH, Mylan N.V., Fresenius Kabi AG, Sun Pharmaceuticals Industries Ltd., Corden Pharma International GmbH, Concordia International Corp., Kyowa Hakko Kirin Co Ltd., Polaris Pharmaceuticals, Inc., MolMed SpA, Ono Pharmaceutical Co. Ltd., Nichi-Iko Pharmaceutical Co., Ltd., AstraZeneca Plc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Novartis AG, and Pfizer Inc.

View Full Report TOC @ https://www.persistencemarketresearch.com/market-research/malignant-mesothelioma-market/toc

About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Malignant Mesothelioma Market to Pegged to be Valued at US$ 600 Mn by 2025 here

News-ID: 796449 • Views:

More Releases from Persistence Market Research

ODM and EMS Wi-Fi Devices Market to Reach US$ 40.8 Billion by 2033 at 15.6% CAGR
ODM and EMS Wi-Fi Devices Market to Reach US$ 40.8 Billion by 2033 at 15.6% CAGR
The global ODM and EMS Wi-Fi devices market is projected to be valued at US$ 14.8 billion in 2026 and is forecast to surge to US$ 40.8 billion by 2033, registering a robust CAGR of 15.6% between 2026 and 2033. This rapid growth reflects the accelerating demand for advanced wireless connectivity solutions across residential, enterprise, and industrial environments. The expansion of 5G infrastructure, enterprise digital transformation strategies, and large-scale IoT
Zink Printing Market to Reach US$ 2,126.0 Million by 2033 at 3.9% CAGR
Zink Printing Market to Reach US$ 2,126.0 Million by 2033 at 3.9% CAGR
Zink Printing Market Size and Trends Analysis The global Zink printing market is projected to be valued at US$ 1,626.5 million in 2026 and is expected to reach US$ 2,126.0 million by 2033, expanding at a CAGR of 3.9% between 2026 and 2033. Zink (Zero Ink) printing technology eliminates the need for ink cartridges by using heat-activated color crystals embedded within specialized paper. This innovation has positioned Zink printers as a
Indium Phosphide Market to Reach US$ 8.7 Billion by 2033 at 5.5% CAGR
Indium Phosphide Market to Reach US$ 8.7 Billion by 2033 at 5.5% CAGR
The global Indium Phosphide (InP) market is poised for steady expansion, with its valuation expected to reach US$ 6.0 billion by 2026 and further grow to US$ 8.7 billion by 2033, registering a CAGR of 5.5% between 2026 and 2033. Indium phosphide, a high-performance compound semiconductor material, is widely used in optoelectronics, high-frequency electronics, and photonic integrated circuits (PICs). The market growth is largely fueled by the accelerating deployment of
Roasted Corn Market to Reach $5.5B by 2033 Driven by Rising Snack Demand
Roasted Corn Market to Reach $5.5B by 2033 Driven by Rising Snack Demand
The global roasted corn market is poised for steady expansion, driven by rising consumer preference for convenient, ready-to-eat snacks and increasing awareness of healthier alternatives to traditional fried snack options. Current market estimates indicate that the roasted corn market is valued at approximately US$ 3.8 billion in 2026 and is projected to reach US$ 5.5 billion by 2033, reflecting a compound annual growth rate (CAGR) of 5.4% between 2026 and

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the